Vildagliptin on glycemic control in newly diagnosed type 2 diabetes in the short-term insulin pump therapy and remission: a prospective, randomized, open, controlled single-center clinical study

Trial Profile

Vildagliptin on glycemic control in newly diagnosed type 2 diabetes in the short-term insulin pump therapy and remission: a prospective, randomized, open, controlled single-center clinical study

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Jul 2014

At a glance

  • Drugs Vildagliptin (Primary) ; Insulin
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 24 Oct 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top